Kids Library Home

Welcome to the Kids' Library!

Search for books, movies, music, magazines, and more.

     
Available items only
Add Marked to Bag Add All On Page
Authors (1-8 of 8)
Adams Christopher P
1
E-Book/E-Doc
 

Agent discretion, adverse selection, and the risk-incentive trade-off


Adams, Christopher P.
[Washington, D.C. : Bureau of Economics, U.S. Federal Trade Commission, 2002] 2002

Rating:

Copies

Location Call No. OPAC Message Status
 Axe Federal Documents Online  FT 1.37/2:255    ---  Available
2
Print Material
 

CBO's model of drug price negotiations under the Elijah E. Cummings Lower Drug Costs Now Act


Adams, Christopher P., author.
Washington, D.C. : Congressional Budget Office, 2021. 2021

Rating:

Copies

Location Call No. OPAC Message Status
 Axe Federal Documents Online  Y 10.11:2021-01    ---  Available
3
Print Material
 

CBO's simulation model of new drug development


Adams, Christopher P., author.
Washington, D.C. : Congressional Budget Office, 2021. 2021

Rating:

Copies

Location Call No. OPAC Message Status
 Axe Federal Documents Online  Y 10.11:2021-09    ---  Available
4
E-Book/E-Doc
 

Does size really matter? empirical evidence on group incentives


Adams, Christopher P.
[Washington, D.C. : Bureau of Economics, U.S. Federal Trade Commission, 2002] 2002

Rating:

Copies

Location Call No. OPAC Message Status
 Axe Federal Documents Online  FT 1.37/2:252    ---  Available
5
E-Book/E-Doc
 

Focusing on demand using eBay data to analyze the demand for telescopes


Adams, Christopher P.
[Washington, D.C. : Bureau of Economics, U.S. Federal Trade Commission, 2003] 2003

Rating:

Copies

Location Call No. OPAC Message Status
 Axe Federal Documents Online  FT 1.37/2:257    ---  Available
6
E-Book/E-Doc
 

Identifying demand in eBay auctions


Adams, Christopher P.
[Washington, DC : Bureau of Economics, U.S. Federal Trade Commission, 2004] 2004

Rating:

Copies

Location Call No. OPAC Message Status
 Axe Federal Documents Online  FT 1.37/2:272    ---  Available
7
E-Book/E-Doc
 

Is it always optimal to "sell the firm" to risk-neutral agent?


Adams, Christopher P.
[Washington, D.C. : Bureau of Economics, U.S. Federal Trade Commission, 2004] 2004

Rating:

Copies

Location Call No. OPAC Message Status
 Axe Federal Documents Online  FT 1.37/2:268    ---  Available
8
E-Book/E-Doc
 

New drug development estimating entry from human clinical trials


Adams, Christopher P.
[Washington, D.C.] : Bureau of Economics, Federal Trade Commission, [2003] 2003

Rating:

Copies

Location Call No. OPAC Message Status
 Axe Federal Documents Online  FT 1.37/2:262    ---  Available
Add Marked to Bag Add All On Page
Locate in results
 
    
Available items only